PTGS2 and hepatocellular carcinoma: Genistein abolishes the increased cyclooxygenase-2 (COX-2) to 5-FU resistant HT-29 colon cancer cells (207) and induces the cleavage of Bid to TRAIL resistant human hepatoma cells (208), exerting its sensitizing effects.